PE20081481A1 - Composiciones de diclorhidrato de azimilida - Google Patents
Composiciones de diclorhidrato de azimilidaInfo
- Publication number
- PE20081481A1 PE20081481A1 PE2007001784A PE2007001784A PE20081481A1 PE 20081481 A1 PE20081481 A1 PE 20081481A1 PE 2007001784 A PE2007001784 A PE 2007001784A PE 2007001784 A PE2007001784 A PE 2007001784A PE 20081481 A1 PE20081481 A1 PE 20081481A1
- Authority
- PE
- Peru
- Prior art keywords
- peaks
- dichlorhydrate
- azimilide
- isopropanol
- refers
- Prior art date
Links
- MREBEPTUUMTTIA-PCLIKHOPSA-N Azimilide Chemical compound C1CN(C)CCN1CCCCN1C(=O)N(\N=C\C=2OC(=CC=2)C=2C=CC(Cl)=CC=2)CC1=O MREBEPTUUMTTIA-PCLIKHOPSA-N 0.000 title abstract 2
- 229950001786 azimilide Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- -1 4-METHYL-1-PIPERAZINYL Chemical class 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical class ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A FORMAS POLIMORFICAS DE AZILIMIDA (E)-1-[[[5-(4-CLOROFENIL)-2-FURANILO]METILEN]AMINO]-3-[4-(4-METIL-1-PIPERAZINIL)BUTILO]-2,4-IMIDAZOLIDINADIONA DICLORHIDRATO, EN FORMA DE HEMI-HIDRATO, ISOPROPANOL Y ANHIDRATO DE AZIMILIDA. LAS CUALES PRESENTAN LAS SIGUIENTES CARACTERISTICAS: 0.5% A 2.5% (w/w) DE AGUA o 0% A 0.3% DE AGUA RESIDUAL; CON PICOS DE DIFRACCION DE RAYOS X A 2TETHA DE 5.95º, 11.9º, 14.88º, 17.66º, 20.89º, 26.03º; o CON PICOS DE 4.96º, 9.25º, 9.92º, 14.9º, 21.17º, 24.56º; Y PICOS DE ABSORBANCIA EN IR A 3512 Y 3450 o 3428 Y 3390 DE NUMEROS DE ONDAS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA QUE CONTIENE APROXIMADAMENTE 9 A 11% DE ISOPROPANOL EN PESO Y A UN PROCEDIMIENTO DE PREPARACION. DICHA COMPOSICION ES DE UTILIDAD EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES, COMO ARRITMIAS CARDIACAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87505106P | 2006-12-15 | 2006-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081481A1 true PE20081481A1 (es) | 2008-11-07 |
Family
ID=39401118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001784A PE20081481A1 (es) | 2006-12-15 | 2007-12-13 | Composiciones de diclorhidrato de azimilida |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20080182858A1 (es) |
| EP (1) | EP2125791A2 (es) |
| JP (1) | JP2010513264A (es) |
| KR (1) | KR20090089416A (es) |
| CN (1) | CN101558063A (es) |
| AR (1) | AR064367A1 (es) |
| AU (1) | AU2007331033A1 (es) |
| BR (1) | BRPI0720265A2 (es) |
| CA (1) | CA2672132A1 (es) |
| CL (1) | CL2007003643A1 (es) |
| IL (1) | IL198807A0 (es) |
| MA (1) | MA30992B1 (es) |
| MX (1) | MX2009006475A (es) |
| PE (1) | PE20081481A1 (es) |
| RU (1) | RU2009117558A (es) |
| SM (1) | SMAP200900061A (es) |
| TW (1) | TW200840578A (es) |
| WO (1) | WO2008072190A2 (es) |
| ZA (1) | ZA200903390B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016256776B2 (en) * | 2009-03-18 | 2018-04-12 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| AU2013248242B2 (en) * | 2009-03-18 | 2016-08-18 | Incarda Therapeutics, Inc | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| EP2413902B1 (en) | 2009-03-18 | 2019-07-17 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| CN101735203B (zh) * | 2009-12-17 | 2012-05-23 | 天津药物研究院 | 盐酸阿齐利特的晶型ⅱ及其制备方法和用途 |
| EP3380152B1 (en) * | 2015-11-27 | 2020-10-28 | Sanofi-Aventis Deutschland GmbH | Medicament injection device |
| WO2017136421A1 (en) | 2016-02-01 | 2017-08-10 | Incarda Therapeutics, Inc. | Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation |
| JP2020519628A (ja) | 2017-05-10 | 2020-07-02 | インカーダ セラピューティクス， インコーポレイテッド | 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法 |
| WO2019183470A2 (en) | 2018-03-22 | 2019-09-26 | Incarda Therapeutics, Inc. | A novel method to slow ventricular rate |
| US11020384B2 (en) | 2019-08-01 | 2021-06-01 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
| CN113861164B (zh) * | 2021-10-29 | 2022-09-20 | 迪嘉药业集团有限公司 | 一种烟碱的结晶制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032645A (en) * | 1975-06-19 | 1977-06-28 | G. D. Searle & Co. | Injectable metronidazole composition |
| DE69232681T2 (de) * | 1991-08-14 | 2003-02-13 | Procter & Gamble Pharmaceuticals, Norwich | 4-oxozyklische harnstoffe mit antiarrhythmische und entfibrillatorische wirkung |
| AU751681B2 (en) * | 1998-04-29 | 2002-08-22 | Lonza Ltd. | Process for making 1,3-disubstituted-4-oxocyclic ureas |
| TR200003136T2 (tr) * | 1998-04-29 | 2001-03-21 | The Procter & Gamble Company | 1,3-İki ikameli-4-oksosiklik ürelerin yapımı ile ilgili yöntem. |
| WO2004101525A1 (en) * | 2003-05-08 | 2004-11-25 | Theravance, Inc. | Crystalline form of aryl aniline beta-2 adrenergic receptor agonist |
-
2007
- 2007-12-07 TW TW096146861A patent/TW200840578A/zh unknown
- 2007-12-11 WO PCT/IB2007/055037 patent/WO2008072190A2/en not_active Ceased
- 2007-12-11 EP EP07849435A patent/EP2125791A2/en not_active Withdrawn
- 2007-12-11 JP JP2009540950A patent/JP2010513264A/ja active Pending
- 2007-12-11 KR KR1020097012327A patent/KR20090089416A/ko not_active Ceased
- 2007-12-11 RU RU2009117558/04A patent/RU2009117558A/ru not_active Application Discontinuation
- 2007-12-11 BR BRPI0720265-2A patent/BRPI0720265A2/pt not_active Application Discontinuation
- 2007-12-11 US US12/001,321 patent/US20080182858A1/en not_active Abandoned
- 2007-12-11 AU AU2007331033A patent/AU2007331033A1/en not_active Abandoned
- 2007-12-11 CA CA002672132A patent/CA2672132A1/en not_active Abandoned
- 2007-12-11 MX MX2009006475A patent/MX2009006475A/es not_active Application Discontinuation
- 2007-12-11 CN CNA2007800464235A patent/CN101558063A/zh active Pending
- 2007-12-13 PE PE2007001784A patent/PE20081481A1/es not_active Application Discontinuation
- 2007-12-14 AR ARP070105639A patent/AR064367A1/es not_active Application Discontinuation
- 2007-12-14 CL CL200703643A patent/CL2007003643A1/es unknown
-
2009
- 2009-05-18 ZA ZA200903390A patent/ZA200903390B/xx unknown
- 2009-05-19 IL IL198807A patent/IL198807A0/en unknown
- 2009-06-15 MA MA31991A patent/MA30992B1/fr unknown
- 2009-07-15 SM SM200900061T patent/SMAP200900061A/it unknown
-
2011
- 2011-06-09 US US13/156,810 patent/US20110237603A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008072190A3 (en) | 2008-11-06 |
| IL198807A0 (en) | 2010-02-17 |
| US20080182858A1 (en) | 2008-07-31 |
| TW200840578A (en) | 2008-10-16 |
| CN101558063A (zh) | 2009-10-14 |
| US20110237603A1 (en) | 2011-09-29 |
| JP2010513264A (ja) | 2010-04-30 |
| ZA200903390B (en) | 2010-04-28 |
| AU2007331033A1 (en) | 2008-06-19 |
| BRPI0720265A2 (pt) | 2014-01-28 |
| RU2009117558A (ru) | 2011-01-20 |
| CA2672132A1 (en) | 2008-06-19 |
| SMAP200900061A (it) | 2009-09-07 |
| AR064367A1 (es) | 2009-04-01 |
| WO2008072190A2 (en) | 2008-06-19 |
| KR20090089416A (ko) | 2009-08-21 |
| EP2125791A2 (en) | 2009-12-02 |
| CL2007003643A1 (es) | 2008-03-24 |
| MX2009006475A (es) | 2009-06-26 |
| MA30992B1 (fr) | 2009-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081481A1 (es) | Composiciones de diclorhidrato de azimilida | |
| AR112074A2 (es) | Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3 | |
| CL2011001082A1 (es) | Compuestos derivados de amino-tetrahidropiranos sustituidos con heterociclos, composicion farmaceutica; y uso en el tratamiento de una afeccion seleccionada de resistencia a la insulina, hiperglicemia y diabetes de tipo 2. | |
| CR11683A (es) | Piridinas y pirazinas como inhibidores de p13k | |
| ATE540932T1 (de) | Hydantoin-derivate als antibakterielle wirkstoffe | |
| WO2007135527A3 (en) | Benzimidazolyl compounds | |
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| NO20076648L (no) | Novel thiophene derivatives | |
| BRPI0915084B8 (pt) | composto, e, composição farmacêutica | |
| GEP20156366B (en) | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use | |
| EP2094118A4 (en) | IMPROVED PERACIC ACID COMPOSITION | |
| EA201071039A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
| CL2008002689A1 (es) | Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia. | |
| WO2007044085A3 (en) | Heteroaryl compounds and their uses as therapeutic agents | |
| PE20081837A1 (es) | Derivados de quinuclinidol como antagonistas de los receptores muscarinicos | |
| WO2007126900A3 (en) | Antifungal agents | |
| UA94606C2 (ru) | Производные тиоксантина, композиция, которая их содержит, и их применение в терапии | |
| MX2010001020A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas. | |
| WO2011025982A3 (en) | Tetracycline compounds | |
| EP2257161A4 (en) | AHCY-HYDROLASE INHIBITOR FOR THE TREATMENT OF HYPERHOMOCYSTEINEMIA | |
| WO2005115392A3 (en) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors | |
| WO2007046867A3 (en) | Piperidine derivatives and their uses as therapeutic agents | |
| MX2007008141A (es) | Composicion farmaceutica de sustancias labiles en medio acido. | |
| DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
| EP2296665A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PREMATURE EJACULATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |